Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Does low-density lipoprotein cholesterol induce inflammation? If so, does it matter? Current insights and future perspectives for novel therapies

Fig. 2

Tentative algorithm for guiding system of care selection of the appropriate treatment customized to the patient’s residual cholesterol versus inflammatory risk, when long-term anti-inflammatory therapy appears to be safe. CV cardiovascular, hsCRP high-sensitivity C-reactive protein, IL interleukin, LDL-C low-density lipoprotein cholesterol, PCSK9 proprotein convertase subtilisin/kexin type 9

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us